Spero Therapeutics shareholders approved increase in authorized common shares to 240 million

Spero Therapeutics, Inc.

Spero Therapeutics, Inc.

SPRO

0.00
  • Spero Therapeutics held its annual shareholder meeting on June 23, 2026.
  • Shareholders ratified PricewaterhouseCoopers as independent registered public accounting firm for fiscal 2026.
  • Shareholders authorized an increase in common stock available for issuance to 240,000,000 shares; the charter amendment was filed and took effect June 23, 2026.
  • Shareholders adopted the 2026 Stock Incentive Plan, authorizing up to 12,895,866 shares for issuance under the plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-283033), on June 25, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.